It was reported that TSC2-deficient cells enhance phosphatidylcholine synthesis via the
Kennedy pathway. 11C-Choline can reflect the metabolic process of choline in vivo by
intravenous injection. The purpose of this study is the ability of 11C-Choline PET/CT to
evaluate the baseline condition of LAM patients and the efficacy of rapamycin after
treatment.